0MSD.IL - COMPUGROUP MEDICAL SE COMPUGROU

IOB - IOB Delayed price. Currency in EUR
71.03
-2.00 (-2.74%)
At close: 4:29PM BST
Stock chart is not supported by your current browser
Previous close73.03
Open72.85
Bid69.25 x 0
Ask72.80 x 0
Day's range70.85 - 73.05
52-week range46.70 - 78.45
Volume2,261
Avg. volume21,245
Market capN/A
Beta (5Y monthly)N/A
PE ratio (TTM)N/A
EPS (TTM)N/A
Earnings dateN/A
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target estN/A
  • Can Compugroup Medical Se ride out the Covid-19 economic shock?
    Stockopedia

    Can Compugroup Medical Se ride out the Covid-19 economic shock?

    Economic shockwaves caused by Covid-19 have plunged stock markets into turmoil, but some shares are better able to absorb this volatility than others - and Com8230;

  • EQS Group

    CompuGroup Medical SE: Annual General Meeting approves change of legal form into a partnership limited by shares (Kommanditgesellschaft auf Aktien, KGaA) and dividend at previous year's level

    DGAP-News: CompuGroup Medical SE / Key word(s): AGM/EGM 13.05.2020 / 17:03 The issuer is solely responsible for the content of this announcement. Koblenz. CompuGroup Medical SE, one of the leading eHealth companies worldwide, held its Annual General Meeting, virtually, today for the first time. This became necessary due to the social distancing regulations in place as a result of the COVID-19 pandemic, which continue to apply. With a majority of 75.67 %, the shareholders of the MDAX company decided to change its legal form into a partnership limited by shares (Kommanditgesellschaft auf Aktien, KGaA). This gives the company additional flexibility in financing future growth and continues to bind the Gotthardt family closely to the company as reliable anchor shareholders.Frank Gotthardt, Chairman of the Management Board and CEO, founded today's CompuGroup Medical SE in 1987 and has since then been at the helm of the company, the shares of which are traded in the MDAX since September 2019. "I am pleased that a vast majority of shareholders followed the proposal of the Management Board and the Supervisory Board today, and I wish to thank all of the shareholders for their trust," emphasizes Frank Gotthardt. "We will continue on our consistent growth course of the past years. Following this change of legal form, we are firmly determined to be even more successful in taking advantage of the enormous opportunities offered by digitization in the healthcare sector for the benefit of all.""The past few weeks, with the dramatic developments during the global COVID-19 pandemic, have shown the great potential that digitization has in the healthcare system," continued Frank Gotthardt. "Video consultations, telemonitoring and electronic patient files are just a few of the applications that bring real added value beyond the current crisis situation. In the current Corona crisis, these applications protect patients, doctors and everyone else who works in the healthcare sector." This is exactly what the high demand for digital solutions shows. Over the past two months approximately 80,000 new customers registered for the CGM video consultation - a quantum leap.All items on the agenda were adopted in the virtual Annual General Meeting with the required majority. Among other things, CompuGroup Medical SE will pay a dividend of EUR 0.50 per share, which is at the previous year's level.As part of the change of legal form, a monistically structured European Stock Corporation (Societas Europaea, SE), CompuGroup Medical Management SE, will join the future CompuGroup Medical SE & Co. KGaA as its general partner. CompuGroup Medical Management SE is indirectly held by Mr. Frank Gotthardt as controlling shareholder. The Administrative Board of CompuGroup Medical Management SE consists of Mr. Frank Gotthardt (Chairman), Dr. Klaus Esser (Deputy Chairman) and Prof. Dr. Daniel Gotthardt.The change of legal form does not change the participation of the shareholders in the company. They will hold the same number of shares in KGaA as they hold in CompuGroup Medical SE prior to the change of legal form. The aggregate number of shares issued will also remain unchanged. However, the shares of the future KGaA will be registered shares as opposed to the current bearer shares. The change of legal form will become effective upon registration with the commercial register.The Supervisory Board of CompuGroup Medical SE & Co. KGaA will comprise of six shareholder representatives and the same number of employee representatives. Mr. Philipp von Ilberg, Dr. Ulrike Handel, Dr. Bettina Volkens, Mr. Matthias Störmer, Prof. Dr. Martin Köhrmann as well as Dr. Michael Fuchs were elected to the Supervisory Board as shareholder representatives. The election of the employee representatives to the Supervisory Board will take place in accordance with the legal regulations after registration of the change of form with the commercial register.Until entry in the commercial register, the current Supervisory Board of CompuGroup Medical SE will remain in force. With a large majority, the shareholders re-elected the four current shareholder representatives for the Supervisory Board, whose term of office ended at the end of the Annual General Meeting. Dr. Klaus Esser is to remain the Chairman of the Supervisory Board. Prof. Dr. Daniel Gotthardt, Dr. Ulrike Handel and Mr. Thomas Seifert were also re-elected to the Supervisory Board.About CompuGroup Medical SE CompuGroup Medical is one of the leading eHealth companies in the world. With a revenue base of EUR 746 million in 2019, its software products are designed to support all medical and organizational activities in doctors' offices, pharmacies, laboratories and hospitals. Its information services for all parties involved in the healthcare system and its web-based personal health records contribute towards safer and more efficient healthcare. CompuGroup Medical's services are based on a unique customer base of more than 1 million users, including doctors, dentists, pharmacists and other health professionals in inpatient and outpatient facilities. With locations in 18 countries and products in 56 countries worldwide, CompuGroup Medical is the eHealth company with one of the highest coverages among eHealth service providers. Approximately 5,800 highly qualified employees support customers with innovative solutions for the steadily growing demands of the healthcare system.You can reach our press archive at: Press releases CGM Group: https://www.cgm.com/corp/presse/presseinformationen/Presse.en.jsp CompuGroup Medical SE Contact for media representatives: Michael Franz Head of Brand Communication P +49 (0) 261 8000-6100 F +49 (0) 261 8000-3100 E-mail: press@cgm.com Contact for analysts and investors: Claudia Thomé Head of Investor Relations P +49 (0) 261 8000-7030 F +49 (0) 261 8000-3200 E-mail: claudia.thome@cgm.com Web: www.cgm.com Social media: Visit us on Twitter, LinkedIn and XING * * *13.05.2020 Dissemination of a Corporate News, transmitted by DGAP - a service of EQS Group AG. The issuer is solely responsible for the content of this announcement. The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. Archive at www.dgap.de * * * Language: English Company: CompuGroup Medical SE Maria Trost 21 56070 Koblenz Germany Phone: +49 (0)261 8000 6200 Fax: +49 (0)261 8000 3200 E-mail: investor@cgm.com Internet: www.cgm.com ISIN: DE0005437305 WKN: 543730 Indices: MDAX, TecDAX Listed: Regulated Market in Frankfurt (Prime Standard); Regulated Unofficial Market in Berlin, Dusseldorf, Hamburg, Munich, Stuttgart, Tradegate Exchange EQS News ID: 1044151 End of News DGAP News Service

  • EQS Group

    CompuGroup Medical SE: Annual General Meeting approves the change of legal form into a partnership limited by shares (Kommanditgesellschaft auf Aktien, KGaA)

    CompuGroup Medical SE / Key word(s): AGM/EGM CompuGroup Medical SE: Annual General Meeting approves the change of legal form into a partnership limited by shares (Kommanditgesellschaft auf Aktien, KGaA) 13-May-2020 / 15:49 CET/CEST Disclosure of an inside information acc. to Article 17 MAR of the Regulation (EU) No 596/2014, transmitted by DGAP - a service of EQS Group AG. The issuer is solely responsible for the content of this announcement. * * *The Annual General Meeting of CompuGroup Medical SE of today has approved the change of legal form of the company, as proposed by the Management Board and the Supervisory Board, into a partnership limited by shares (Kommanditgesellschaft auf Aktien, KGaA) under the name "CompuGroup Medical SE & Co. KGaA". The general partner is CompuGroup Medical Management SE, a monistically structured European Stock Corporation (Societas Europaea, SE), which is held by the founder of the company and Chairman of the Management Board, Mr. Frank Gotthardt, as the controlling shareholder.The participation of the shareholders in the company will not change as a result of the change of legal form. They will hold the same number of no-par value shares in the KGaA as they hold today, prior to the change of legal form, in CompuGroup Medical SE. The aggregate number of shares issued will also remain unchanged. The change of legal form will become effective upon registration with the commercial register. Contact: Claudia Thomé Head of Investor Relations CompuGroup Medical SE email: claudia.thome@cgm.com phone +49 261 8000 7030 phone +49 261 8000 6200 * * *13-May-2020 CET/CEST The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. Archive at www.dgap.de * * * Language: English Company: CompuGroup Medical SE Maria Trost 21 56070 Koblenz Germany Phone: +49 (0)261 8000 6200 Fax: +49 (0)261 8000 3200 E-mail: investor@cgm.com Internet: www.cgm.com ISIN: DE0005437305 WKN: 543730 Indices: MDAX, TecDAX Listed: Regulated Market in Frankfurt (Prime Standard); Regulated Unofficial Market in Berlin, Dusseldorf, Hamburg, Munich, Stuttgart, Tradegate Exchange EQS News ID: 1044021 End of Announcement DGAP News Service

  • What Is CompuGroup Medical Societas Europaea's (ETR:COP) P/E Ratio After Its Share Price Rocketed?
    Simply Wall St.

    What Is CompuGroup Medical Societas Europaea's (ETR:COP) P/E Ratio After Its Share Price Rocketed?

    CompuGroup Medical Societas Europaea (ETR:COP) shareholders are no doubt pleased to see that the share price has had a...

  • Can You Imagine How CompuGroup Medical Societas Europaea's (ETR:COP) Shareholders Feel About The 81% Share Price Increase?
    Simply Wall St.

    Can You Imagine How CompuGroup Medical Societas Europaea's (ETR:COP) Shareholders Feel About The 81% Share Price Increase?

    CompuGroup Medical Societas Europaea (ETR:COP) shareholders might be concerned after seeing the share price drop 23...

  • Here’s What CompuGroup Medical Societas Europaea’s (ETR:COP) Return On Capital Can Tell Us
    Simply Wall St.

    Here’s What CompuGroup Medical Societas Europaea’s (ETR:COP) Return On Capital Can Tell Us

    Today we are going to look at CompuGroup Medical Societas Europaea (ETR:COP) to see whether it might be an attractive...

  • Is CompuGroup Medical Societas Europaea (ETR:COP) A Smart Choice For Dividend Investors?
    Simply Wall St.

    Is CompuGroup Medical Societas Europaea (ETR:COP) A Smart Choice For Dividend Investors?

    Today we'll take a closer look at CompuGroup Medical Societas Europaea (ETR:COP) from a dividend investor's...

  • Can CompuGroup Medical Societas Europaea (ETR:COP) Maintain Its Strong Returns?
    Simply Wall St.

    Can CompuGroup Medical Societas Europaea (ETR:COP) Maintain Its Strong Returns?

    While some investors are already well versed in financial metrics (hat tip), this article is for those who would like...

  • If You Like EPS Growth Then Check Out CompuGroup Medical Societas Europaea (ETR:COP) Before It's Too Late
    Simply Wall St.

    If You Like EPS Growth Then Check Out CompuGroup Medical Societas Europaea (ETR:COP) Before It's Too Late

    Like a puppy chasing its tail, some new investors often chase 'the next big thing', even if that means buying 'story...

  • Is CompuGroup Medical Societas Europaea (ETR:COP) Excessively Paying Its CEO?
    Simply Wall St.

    Is CompuGroup Medical Societas Europaea (ETR:COP) Excessively Paying Its CEO?

    In 2008 Frank Gotthardt was appointed CEO of CompuGroup Medical Societas Europaea (ETR:COP). This analysis aims first...

  • Here's What CompuGroup Medical Societas Europaea's (ETR:COP) P/E Is Telling Us
    Simply Wall St.

    Here's What CompuGroup Medical Societas Europaea's (ETR:COP) P/E Is Telling Us

    Today, we'll introduce the concept of the P/E ratio for those who are learning about investing. We'll look at...

  • Could The CompuGroup Medical Societas Europaea (ETR:COP) Ownership Structure Tell Us Something Useful?
    Simply Wall St.

    Could The CompuGroup Medical Societas Europaea (ETR:COP) Ownership Structure Tell Us Something Useful?

    If you want to know who really controls CompuGroup Medical Societas Europaea (ETR:COP), then you'll have to look at...

  • Are CompuGroup Medical Societas Europaea’s Returns On Capital Worth Investigating?
    Simply Wall St.

    Are CompuGroup Medical Societas Europaea’s Returns On Capital Worth Investigating?

    Today we'll look at CompuGroup Medical Societas Europaea (ETR:COP) and reflect on its potential as an investment...

  • Is CompuGroup Medical Societas Europaea (ETR:COP) A Risky Investment?
    Simply Wall St.

    Is CompuGroup Medical Societas Europaea (ETR:COP) A Risky Investment?

    Howard Marks put it nicely when he said that, rather than worrying about share price volatility, 'The possibility of...

  • How Does CompuGroup Medical Societas Europaea (FRA:COP) Stand Up To These Simple Dividend Safety Checks?
    Simply Wall St.

    How Does CompuGroup Medical Societas Europaea (FRA:COP) Stand Up To These Simple Dividend Safety Checks?

    Could CompuGroup Medical Societas Europaea (FRA:COP) be an attractive dividend share to own for the long haul...

  • Here's What CompuGroup Medical Societas Europaea's (FRA:COP) P/E Is Telling Us
    Simply Wall St.

    Here's What CompuGroup Medical Societas Europaea's (FRA:COP) P/E Is Telling Us

    This article is written for those who want to get better at using price to earnings ratios (P/E ratios). We'll apply a...

  • Here's Why I Think CompuGroup Medical Societas Europaea (FRA:COP) Is An Interesting Stock
    Simply Wall St.

    Here's Why I Think CompuGroup Medical Societas Europaea (FRA:COP) Is An Interesting Stock

    It's only natural that many investors, especially those who are new to the game, prefer to buy shares in 'sexy' stocks...

  • Should You Worry About CompuGroup Medical Societas Europaea's (FRA:COP) CEO Pay Cheque?
    Simply Wall St.

    Should You Worry About CompuGroup Medical Societas Europaea's (FRA:COP) CEO Pay Cheque?

    Frank Gotthardt became the CEO of CompuGroup Medical Societas Europaea (FRA:COP) in 2008. This analysis aims first to...

By using Yahoo, you agree that we and our partners can use cookies for purposes such as customising content and advertising. See our Privacy Policy to learn more